Please complete our survey to be entered into a...
Obesity, Inflammation in Adolescence May Up Colon Cancer Risk
A 35-year study of males in Sweden found a...
New News Item
The subsidiary of DanDrit Biotech USA, Inc. ("DanDrit"), a...
Why do some forms of cancer receive more research funding than others?
Breast cancer research receives more money than any other...
Most patients at public hospitals receive surgery for major cancers within 30 days
The National Health Performance Authority's (NHPA) study focused on...
Please find a list of our archived newsletters.
Cancon Newsletter 1
Cancon newsletter 2
Cancon Newsletter 3
Cancon Newsletter 4
Cancon newsletter 5
I really cannot believe EuropaColon is celebrating its 10th Anniversary this year and also the 6th European Colorectal Cancer Awareness Month ... it seems as if it was only a few weeks ago that it was suggested to me that colorectal cancer patients in Europe needed more support than they were getting.
Little did I expect when we started EuropaColon in 2004 that we would achieve as much as we have, nor seen the many changes that we are witnessing not only in the treatment and care of people with colorectal cancer but also in policy terms with considerable progress on colorectal cancer screening, helping to diagnose many more people across Europe.
When we started there were only 3 colorectal cancer patient organisations in the whole of Europe. By the end of 2013 there were 25 Groups signed up with EuropaColon and 8 more already wanting to join in 2014. No longer do we only cover the EU but also further afield - Turkey, Serbia, Israel, Russia and Ukraine. This reflects not only the appeal of being part of an extend organisation but also the need to support colorectal cancer patients.
As the numbers of newly diagnosed people increases year on year it is our mission to identify ways to provide support and assistance for them, to raise awareness of screening amongst the citizens of Europe and help people realise that health is their responsibility and that only they can make a difference to their health outcomes.
I would like to pay tribute to all those people in all our groups who have worked so hard to achieve these goals over the years, they are the back bone of EuropaColon for they are at the coal face striving to support patients in their country, often against considerable odds.
To all of you I would like to extend a very big THANK YOU!
Jolanta Gore-Booth, Founder/CEO of EuropaColon
2013 Annual Review
The Annual Review is a summary of our projects and initiatives in 2013
Click here to read our Patient Stories
For patients, written by patients; to manage your illness.
RAS Biomarkers Testing Explained
Why RAS testing of your tumour is important